URGN
UroGen Pharma·NASDAQ
--
--(--)
--
--(--)
6.16 / 10
Outperform
Technical rating is Outperform with a 6.16 score. Long lower and upper shadows show strong bullish signals, while the Marubozu white pattern adds bearish pressure. Overall the chart suggests cautious optimism.
Analysis Checks(2/3)
Long Lower Shadow
Score8.73/10
Win Rate68.18%
Hist. Signals44
Avg Return6.15%
Score8.73/10
Win Rate68.18%
Hist. Signals44
Avg Return6.15%
Marubozu White
Score1.87/10
Win Rate36.36%
Hist. Signals11
Avg Return0.56%
Score1.87/10
Win Rate36.36%
Hist. Signals11
Avg Return0.56%
Long Upper Shadow
Score7.88/10
Win Rate62.50%
Hist. Signals40
Avg Return10.42%
Score7.88/10
Win Rate62.50%
Hist. Signals40
Avg Return10.42%
Long Lower Shadow
Score8.73/10
Win Rate68.18%
Hist. Signals44
Avg Return6.15%
Score8.73/10
Win Rate68.18%
Hist. Signals44
Avg Return6.15%
Long Upper Shadow
Score7.88/10
Win Rate62.50%
Hist. Signals40
Avg Return10.42%
Score7.88/10
Win Rate62.50%
Hist. Signals40
Avg Return10.42%
Marubozu White
Score1.87/10
Win Rate36.36%
Hist. Signals11
Avg Return0.56%
Score1.87/10
Win Rate36.36%
Hist. Signals11
Avg Return0.56%
Technical Analysis of URGN?
- URGN presents a Outperform setup with a Technical Score of 6.16/10. Key technical indicators highlight an RSI of 51.01 and a MACD of 0.17, with the trend anchored by the 50-Day SMA at 19.78. Traders should monitor key support at 17.37 and resistance at 18.56.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
